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about concepts and practices of the CHW in some countries of South America. That
information will be useful to design a questionnaire addressed to healthcare man-
agers in those countries. METHODS: Publications review about CHW. The search-
ing has been done through the data bases LILACS andMEDLINE since 1970 till now.
The used keywords were: Agente Comunitário de Saúde, Agente Comunitario de
Salud, Community Health Aides, Community Health Workers, Lay Health Worker.
The countries includedwere Bolivia, Brazil, Colombia, Ecuador, and Peru RESULTS:
There were founded out 254 articles, 63% are later than 2000 and 62% come from
Brazil. Besides that, there were an previous literature review and reports of na-
tional and international organizations. The publications raise different issues re-
lated to CHW: roles and activities (generalist and specialist), recruitment and se-
lection, training, supervision and support, relationships with the formal health
services, incentives. The CHW may improve the access and the coverage of the
basic public healthcare services. Unlike, Bolivia, Colombia, Ecuador and Peru,
where most of the participation is voluntary and supported by NGO, in Brazil the
CHW are members of the Nacional Health System through the Family Health
Program. CONCLUSIONS: Literature have reported that CHW carry out a variety of
health tasks, and that CHW deliver a wide range of interventions in such areas as
maternal and child health, primary health care, malaria, tuberculosis and HIV/
AIDS prevention and control.
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TRENDS OF VITAMIN D PRESCRIBING AMONG ELDERLY AMERICANS: RESULTS
FROM NATIONAL AMBULATORY MEDICAL CARE SURVEYS 2000 TO 2009
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Washington, DC, USA, 2Howard University, Washington, DC, USA
OBJECTIVES: To evaluate the current national trends in Vitamin D prescribing
among the elderly seeking care in office-based physician provider settings.
METHODS: Cross-sectional study was conducted using the National Ambulatory
Medical Care Survey (NAMCS) data from 2000 to 2009. All ambulatory office visits
made by the elderly aged 65 years of age were included in the study. Bivariate
associations between vitaminD and study variables such as patient demographics,
region, physician’s specialty, insurance status, and osteoporosis diagnosis were
evaluated using chi square tests. Logistic regression analyses were conducted to
determine the predictive factors associated with a vitamin D. All analyses were
performed with SAS statistical software, version 9.1, at an alpha of 0.05. RESULTS:
Of the 279,819 office-based physician visits made by the NAMCS participants from
2000 through 2009, there were 74,904(26.7%) visits that met the inclusion criteria.
This estimate represented 2.4 billion physician-office visits from the elderly in the
United States during the 10-year period. Of the included visits, 1,112 (1.91%) were
associated with a vitamin D. Race was a significant predictor in both the adjusted
and unadjusted models. Visits from other races were two times more likely to
include vitamin D when compared to white race (Adjusted OR  1.54; 95% CI 1.17-
2.03), while visits made by black patients were less likely to include vitamin D
therapy (Adjusted OR  0.43; 95% CI 0.38-0.50). The visits made by osteoporosis
patients were five times more likely to be associated with vitamin D therapy than
visitsmade by patients without the diagnosis (Adjusted OR5.23; 95% CI 4.04-6.77).
CONCLUSIONS: This study indicated that very few patients were prescribed vita-
min D. The overall prescribing patterns of vitamin D therapy, however, showed a
steady and continuous increase during past decade in the United States.
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EVALUATION OF PRESCRIBER PERCEPTIONS OF A NEAR-REAL TIME FAX ALERT
PROGRAM FOR POTENTIAL DRUG-DRUG INTERACTIONS
Armstrong EP1, Malone DC1, Hines LE1, Wang SM2, Patel BV2
1University of Arizona, Tucson, AZ, USA, 2MedImpact Healthcare Systems, Inc., San Diego, CA,
USA
OBJECTIVES: To determine prescribers’ perceptions of near-real time messaging
for potential drug-drug interactions (PDDIs) using a fax alert drug utilization review
intervention.METHODS: This was a 6-month prospective studywhere a pharmacy
benefitmanager (PBM) distributed evidence-based summaries of 18 different PDDIs
that included references and suggested management strategies. Fax alerts were
individualized letters sent to the prescriber of the 2nd drug of a PDDI for an indi-
vidual patient. A 16-item questionnaire to assess prescribers’ perceptions of the
intervention accompanied each individualized PDDI evidence-based summary.
Descriptive and multivariate logistical regression analyses were used to assess
questionnaire responses. RESULTS: A total of 8075 fax alerts were distributed and
977 returned questionnaires, yielding a 12.1% response rate. 848 (86.8%) responses
were completed by physicians and 71 (7.3%) completed by nurse practitioners. The
most common PDDI fax alerts sent were for warfarin-statin (3511, 43.5%) and war-
farin-thyroid (2111, 26.1%) interactions. 42.6% of respondents agreed or strongly
agreed that fax alerts were a good way to communicate with them. A total of 37.5%
of respondents, however, either agreed or strongly agreed that the fax alert was a
“waste of my time.” 59.1% of respondents either disagreed or strongly disagreed
that theywould prefer to receive a telephone call when interactions like this occur.
50.5% indicated their computer system provided drug interaction alerts. When
asked to evaluate the evidence-based information provided in the alert, carbam-
azepine-macrolide, ciprofloxacin-tizanidine, and statin-macrolide alerts were
rated more favorable than other PDDIs. Prescribers who had received alerts and
specialists were less likely to respond to the questionnaire (OR0.685, p0.0001
and OR0.851, p0.0205, respectively). CONCLUSIONS: PBMs detect and notify
prescribers of PDDIs during claims adjudication. This study found that some pre-
scribers valued fax alerts, especially for less well-known PDDIs. PDDI alert pro-
grams should carefully select PDDIs and other screening criteria to ensure prescrib-
ers respond to messaging.
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ANALYSIS OF FACTORS INFLUENCING DRUGS PRESCRIPTION DECISION
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OBJECTIVES: In Ukraine currently there is no national reimbursement system for
pharmaceutical products andmajor part of pharmaceutical provision, even in hos-
pitals, is covered by out-of-pocket payments of patients. The aim of this study was
to define what factors have an impact on drugs prescription process by hospital
clinical specialists in Ukraine.METHODS: A brief questionnaire was distributed to
conventional sample of 299 doctors with different specializations (surgeons, anes-
thesiologists, pulmonologists) from four Ukrainian cities (Odessa, Kiev, Dniprope-
trovsk, Lviv). Doctors were proposed to rank on10 points’ scale effectiveness, price,
efficiency, and number of patients a month he/she is ready to prescribe an antibi-
otic drug. A dependence between ranking of effectiveness, price, and efficiency of
the drug and a number of patients the doctor was ready to prescribe it were ana-
lyzed in SPSS using correlation and linear regression analyses. RESULTS: The re-
sponders’ missing rate was equal to 1% due to convenient sample selection and
face-to-face questionnaire distribution. The difference in answers within doctors
of different specializations was not statistically significant. Price of the drug was
negatively associated with frequency of drug’s prescription for doctors of all spe-
cializations (Beta  -0.171; Sig0.004). There were no difference is ranking of effi-
ciency and effectiveness (Pearson correlation 0.684; Sig 0.000). CONCLUSIONS: As
we conclude from the analysis, practical doctors in Ukraine highly associate effi-
ciency with effectiveness of the medical products. Though, clinical effectiveness
has an impact on prescription practice, the price is a determinant.
PHP87
USING THE THEORY OF PLANNED BEHAVIOR TO PREDICT TEXAS
PHARMACISTS’ INTENTION TO REPORT SERIOUS ADVERSE DRUG EVENTS TO
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OBJECTIVES: To use the theory of planned behavior (TPB) to predict Texas phar-
macists’ intention to report serious adverse drug effects (ADEs) to the Food and
Drug Administration (FDA).METHODS: Data were collected from practicing Texas
pharmacists using a mail questionnaire. The study measured intention to report
serious ADEs, attitude (A), subjective norm (SN), perceived behavioral control (PBC)
and demographic and practice characteristics. Intention (3 items) was measured
using a 7-point unipolar scale ranging from extremely unlikely (1) to extremely
likely (7). Attitude (5 items), SN (3 items) and PBC (2 items) were measured on a
7-point bipolar scale ranging from -3 (e.g., strongly disagree) to 3 (e.g., strongly
agree). Themodelwas run usingmultiple regression analysis.RESULTS:Amajority
of the 377 respondents were male (52.9%) and Caucasian (70.2%). Overall, pharma-
cists intended to report ADEs (mean 15.87, SD 4.22; range: 3-21), had a favorable
attitude toward reporting (mean  4.62, SD  4.92; range: -12 to 15), had a favor-
able SN (mean 5.65, SD 2.99; range:-5 to9) and strong PBC (mean 3.54, SD
2.69; range: -6 to6). A ( 0.221, p 0.001), SN ( 0.438, p 0.001) and PBC (
0.028, p  0.05) together accounted for 34.0 percent of the variance in intention to
report serious ADEs to the FDA (F  63.60, d.f.  3, 370, p 0.001). CONCLUSIONS:
Pharmacists showed a strong positive intent to report serious ADEs to the FDA.
Attitude and SN were significant predictors of intent. Strategies to help pharma-
cists report more ADEs should focus on helping pharmacists see the value of re-
porting and altering their perception of social pressure towards reporting. The TPB
has utility in predicting ADE reporting behavior.
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NATIONAL PATTERNS AND TRENDS OF OFF-LABEL USE OF ANTIPSYCHOTIC
MEDICATIONS IN THE ELDERLY FOLLOWING FDA BLACK BOX WARNINGS
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OBJECTIVES:There are conflicting reports as towhether two FDA “black box”warn-
ings regarding risk of mortality related to use of antipsychotic medications to treat
patients aged 65 with dementia and a growing body of evidence of other serious
adverse effects has resulted in decreased use. This analysis explores trends and
patterns of “off-label” use of antipsychotics in the elderly.METHODS: Longitudinal
analysis of a large nationally representative administrative claims database (2005-
2010). The sample includes Medicare, Medicaid and commercially insured patients
aged 65 enrolled 11-12monthswith at least three ormore prescription fills for the
same antipsychotic drug. RESULTS:Themajority of antipsychotic prescribing is for
“off label” conditions. Of the elderly 65 treated with antipsychotics in 2010, 32.8%
had a diagnosis of dementia, 24.3% anxiety disorder, and 20.9% depression; 11.3%
and 10.8% were for approved conditions bipolar disorder and schizophrenia. In
contrast to recent studies reporting significant declines in use of antipsychotics to
treat symptoms of dementia, this analysis reveals high and increasing rates of
use—20.6% of patients with dementia were prescribed antipsychotics in 2010. This
represents an 83 percent increase from 2005 (first black box warning for atypical
antipsychotics issued), but a slight decline from the peak rate of 21.8% in 2008 (FDA
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warning extended to conventional antipsychotics). A 2011 AHRQ comparative ef-
fectiveness review supports efficacy of certain antipsychotics for dementia and
anxiety disorder, but prescribing of drugs without supporting evidence continues
in practice. For example, while aripiprazol, olanzapine and risperidone were found
to have small but significant benefits for dementia symptoms, this analysis showed
quetiapine was most prescribed in this population; haloperidol was prescribed
more than twice as often as aripiprazole. CONCLUSIONS: In spite of the clinical
findings, this analysis found growing use of antipsychotic medications in the el-
derly population and prescribing of specific drugs in the absence of supporting
evidence.
PHP89
KOREAN RECOMMENDATIONS ON HEALTH ECONOMIC EVALUATION (2ND AND
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OBJECTIVES: Korea’s Health Insurance Review and Assessment Service (HIRA) has
been in charge of updating economic evaluation (EE) guideline. The purpose of this
study is to provideminimum standards for submissions, thus increase the compa-
rability between submissions and help decision makers to reach consistent reim-
bursement decisions. METHODS: To prioritize the topics of EE guideline revision,
HIRA has reviewed foreign EE guidelines focusing on currently updated topics, and
evaluated practical and theoretical needs for updating those topics. Gaps between
current recommendations and domestic practice patterns were assessed by eval-
uating dossiers submitted to HIRA for reimbursement decision. In addition, survey
results from pharmaceutical companies as well as decision makers regarding cur-
rent guideline were considered. In developing current revision, experts meetings
were held 6 times, and working group meetings with pharmaceutical companies
were held 4 times to reach as much consensus as possible. RESULTS: Current EE
recommendations are in line with most of foreign EE guidelines, yet the gap be-
tween current recommendations and domestic reality emerged due to lack of high
quality domestic data. Some vague expressions have been noted. To reduce con-
fusion,we clarified the level of data requirement (must, should, preferred) based on
data availability and strength of the evidence. We stipulate QALY measurement,
modeling methods, sensitivity analysis, and perspective in this revision. Minor
updates were also included. CONCLUSIONS: Current revision strives to reduce
comparability and consequently, enhance comparability among submissions by
providing concrete recommendations.
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CASE-MIX ADJUSTMENT OF ADHERENCE-BASED PHARMACY QUALITY
INDICATOR SCORES
Dharmarajan S, Banahan BF, Bentley JP, West-Strum D
University of Mississippi, University, MS, USA
OBJECTIVES: To evaluate three different methods to compute risk-adjusted phar-
macy performance scores based on adherence-based pharmacy quality indicators.
METHODS: This retrospective cohort study used the 2007 Mississippi Medicare
administrative claims dataset. Patient medication adherence was assessed using
the proportion of days covered (PDC) measures proposed by the Pharmacy Quality
Alliance for seven therapeutic classes of medications. Pharmacy performance
scores were computed for all pharmacies serving Medicare beneficiaries in the
state. Risk-adjusted pharmacy performance scores were computed using a classi-
cal logistic regression model (Method 1), a hierarchical random effects model
(Method 2) and the shrinkage estimators of the random-effects model (Method 3).
Patient demographics, income subsidy status, and co-morbidity burden were used
as variables for risk adjustment. The agreement in classification of pharmacies
based on unadjusted and adjusted scores was measured using Cohen’s kappa
coefficient. RESULTS: The logistic regressionmodel and the random-effects model
displayed good predictive ability (c-statistic0.7) for all therapeutic classes. The
residual intraclass correlation coefficient ranged from 0.008 to 0.012 indicating that
although pharmacy-level factors may have a significant impact, they are not as
important as patient-level factors in determining adherence. Higher levels of
agreement were observed between pharmacy classifications based on unadjusted
scores and risk-adjusted scores obtained from Methods 1 and 2 (0.5kappa0.74)
with the percentage change in classification ranging from 16.3%-28.4%. Scores
based on Method 3 produced fewer outliers and showed minimal agreement with
unadjusted scores (0.19kappa0.35). When compared to risk-adjusted scores,
unadjusted scores classified 8-12% of the low performing pharmacies as high per-
forming and classified 20-30% of the pharmacies in the top 20% as low performers.
CONCLUSIONS: Risk-adjusted scores produced more robust indicators of phar-
macy quality than unadjusted scores. Not adequately addressing the effects of
patient case-mix while measuring quality could have severe implications if these
measures are used for pay for performance programs or generating quality report
cards.
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FACTORS AFFECTING SERUM POTASSIUM MEASUREMENTS AFTER INITIATION
OF SPIRONOLACTONE AT AN ACADEMIC MEDICAL CENTER
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OBJECTIVES: Serumpotassium levels should be assessed periodically following the
initiation of spironolactone treatment. This study examined the rate of laboratory
follow-up and factors affecting it at an academic medical center.METHODS: Adult
patients starting spironolactone treatment between January 1, 2008 and September
30, 2010 were studied. Subjects were excluded if the indicated disease was not
followed up at the medical center, or the exact date of the first spironolactone
prescription was unknown. Data were collected by computer query and chart re-
view. Survival analysis examined the factors predicting the time to first serum
potassium testing after spironolactone initiation. RESULTS: A total of 161 patients
were included (mean age 51.1 years, 57% female), 29% of whom had some renal
impairment (creatinine clearance 60 ml/min). Spironolactone was most com-
monly used for ascites/edema due to primary liver disease (45.3%), followed by
congestive heart failure (19.3%) and polycystic ovary syndrome or other hormone-
related disorders (18.6%). Themedian time to first potassium testwas 22 days. After
adjusting for age, gender, renal function and insurance status, medical indication
was the only factor impacting time to first potassium check-up. Compared to pa-
tients with primary liver disease, patients who used spironolactone for ascites/
edema not due to hepatic or cardiac causes (e.g., non-hepatic malignancy, ne-
phrotic syndrome) were likely to have a potassium level checked earlier (hazard
ratio [HR]2.2, 95% CI1.04-4.6), whereas potassium testing was more likely to be
delayed in patients with hormone-related disorders (HR0.4, 95% CI0.2-0.9) or
hypertension (HR0.4, 95% CI0.2-0.8). CONCLUSIONS: Medical indication was
significantly predictive of the time to first potassium check in patients receiving
spironolactone. It is surprising that renal dysfunction was not a factor, while the
association with indication has many possible explanations from increased rou-
tine lab testing for some indications and higher risks of hyperkalemia complica-
tions. Further studies are needed to validate and understand these data.
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OBJECTIVES:Medical errors cause approximately 44,000 to 98,000 injuries annually
in the United States (US). This study estimated the occurrence of medical errors
and associated costs using actuarial methodology developed by Milliman, Inc. ap-
plied to Premier hospital data. METHODS: The Milliman study utilized an expert
panel to estimate how often medical injuries were likely to be associated with a
medical error rather than the underlying disease. Injuries were classified into five
groups based on the likelihood that they were associated with amedical error. The
midpoint of each range of likelihood of medical error was applied to the frequency
of each medical injury to establish the rate of medical error. This study utilized
Milliman’s ranges and midpoints applied to Premier data. Injury rates, error esti-
mates and cost-per-error estimates were developed from Premier 2008-2009 data.
A visit qualified as an injury visit if1 of 97 injury groupings identified byMilliman
occurred. Non-injury control groups were established using propensity score
matching. Population estimates were projected from Premier to all US acute care
hospitals. RESULTS: While the focus of the earlier report was health plan claims
data, this study utilized hospital billing records to demonstrate direct cost of med-
ical errors to hospitals. The rates of medical errors were similar to the Milliman
study and both studies found pressure ulcers and postoperative infection were the
most common types ofmedical errors.Milliman estimated the total cost ofmedical
errors to be approximately $17 billion in 2008. This analysis found that hospitals
bear approximately 1 billion in costs related to medical errors. CONCLUSIONS:
Utilizing methods developed by Milliman, this study estimated the rates and cost
of medical errors to hospitals utilizing hospital billing data, revealing similar pat-
terns of errors.
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IMPACT OF PRESCRIPTION MONITORING PROGRAMS ON PHARMACISTS’
CONTROLLED SUBSTANCE DISPENSING BEHAVIOR
Wixson SE, Talbert J, Blumenschein K, Freeman PR
University of Kentucky, Lexington, KY, USA
OBJECTIVES: Prescription drug monitoring programs (PDMPs) are viewed as a tool
to reduce abuse and diversion of prescription controlled substances (CS), although
little is known about their effectiveness in achieving these goals. The purpose of
this project was to assess the impact of the Kentucky All Schedule Prescription
Electronic Reporting program (KASPER) on pharmacists’ dispensing behavior and
to evaluate its perceived effectiveness in reducing drug abuse, diversion, and doc-
tor shopping. METHODS: Surveys were mailed to 2,018 pharmacists in Kentucky.
After two weeks, a reminder postcard and second survey were sent to non-re-
sponders. Responseswere coded and descriptive analysiswas conducted in STATA
11. RESULTS: Responses were received from 575 pharmacists (response rate 
28.5%). The majority (77%) indicated they had requested a patient’s CS history
through KASPER. For those who had not utilized KASPER, the primary reason was
lack of Internet access at the practice-site. When asked if their CS dispensing has
changed since KASPER implementation, 67% indicated no change while 13% indi-
cated a decrease in dispensing and 15% indicated an increase. For those reporting
a decrease, reasons cited include implementation of KASPER (36%), increased law
enforcement activity (15%) and media coverage of drug abuse and diversion (8%).
Themajority (83%) of respondents believe that KASPER is an effective tool to reduce
drug abuse and diversion and 79% feel it is an effective tool to reduce doctor
shopping. CONCLUSIONS: Internet access was the primary reason for not using
KASPER. Most pharmacists have not perceived a change in CS dispensing since
A29V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 1 – A 2 5 6
